FR2150236A2 - Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use - Google Patents

Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use

Info

Publication number
FR2150236A2
FR2150236A2 FR7130825A FR7130825A FR2150236A2 FR 2150236 A2 FR2150236 A2 FR 2150236A2 FR 7130825 A FR7130825 A FR 7130825A FR 7130825 A FR7130825 A FR 7130825A FR 2150236 A2 FR2150236 A2 FR 2150236A2
Authority
FR
France
Prior art keywords
anthelmintic
imidazo
veterinary use
mammalian toxicity
low mammalian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7130825A
Other languages
French (fr)
Other versions
FR2150236B2 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc SA
Original Assignee
Rhone Poulenc SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc SA filed Critical Rhone Poulenc SA
Priority to FR7130825A priority Critical patent/FR2150236A2/en
Priority to IL37752A priority patent/IL37752A/en
Priority to CH1614772A priority patent/CH532601A/en
Priority to HURO628A priority patent/HU163150B/hu
Priority to CA123264A priority patent/CA940131A/en
Priority to SE11891/71A priority patent/SE368828B/xx
Priority to LU63927D priority patent/LU63927A1/xx
Priority to CH1372371A priority patent/CH532600A/en
Priority to DK458771AA priority patent/DK131345B/en
Priority to BE772835A priority patent/BE772835A/en
Priority to CS890573A priority patent/CS161784B2/cs
Priority to AU33735/71A priority patent/AU453067B2/en
Priority to AT853872A priority patent/AT309434B/en
Priority to NL717112971A priority patent/NL145553B/en
Priority to DE2147103A priority patent/DE2147103C3/en
Priority to ES395260A priority patent/ES395260A1/en
Priority to GB4400371A priority patent/GB1318859A/en
Priority to ES403910A priority patent/ES403910A1/en
Publication of FR2150236A2 publication Critical patent/FR2150236A2/en
Priority to SU1936093A priority patent/SU504481A3/en
Priority to JP4460574A priority patent/JPS5117558B2/ja
Application granted granted Critical
Publication of FR2150236B2 publication Critical patent/FR2150236B2/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Abstract

Cpds. (I): (where R and R1 = H or 1-4C alkyl, R2 = 1-4C alkyl as well as their acid-addition salts and 4 degrees ammonium derivs. have anthelmintic activity against e.g. intestinal Strongylides in horses Ankylostome caninum, Toxocara canis and leonina etc. in dogs, Haemonchus contortus, Nematodirus battus etc. in sheep etc.
FR7130825A 1970-09-21 1971-08-25 Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use Granted FR2150236A2 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
FR7130825A FR2150236A2 (en) 1971-08-25 1971-08-25 Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use
IL37752A IL37752A (en) 1970-09-21 1971-09-17 Imidazo(4,5-b)pyridine-2-carbamic acid derivatives,processes for their preparation and pharmaceutical and veterinary compositions containing the same
HURO628A HU163150B (en) 1970-09-21 1971-09-20
CA123264A CA940131A (en) 1970-09-21 1971-09-20 Derives de l'imidazo (4,5 b) pyridine, leur preparation et les compositions qui les contiennent
SE11891/71A SE368828B (en) 1970-09-21 1971-09-20
LU63927D LU63927A1 (en) 1970-09-21 1971-09-20
CH1372371A CH532600A (en) 1970-09-21 1971-09-20 Process for the preparation of novel imidazo (4,5-b) pyridine derivatives
DK458771AA DK131345B (en) 1970-09-21 1971-09-20 Analogous process for the preparation of imidazo / 4,5-b / -pyridines or acid addition salts or quaternary ammonium salts thereof.
BE772835A BE772835A (en) 1970-09-21 1971-09-20 NEW DERIVATIVES OF IMIDAZO (-4,5-B) PYRIDINE THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM
CS890573A CS161784B2 (en) 1971-08-25 1971-09-20
CH1614772A CH532601A (en) 1971-08-25 1971-09-20 Anthelmintic imidazo (4,5-b) pyridine derivs
AT853872A AT309434B (en) 1971-08-25 1971-09-21 PROCESS FOR THE PRODUCTION OF NEW IMIDAZO (4,5-B) PYRIDINE DERIVATIVES AND THEIR ACID ADDITION SALTS AND QUATERNAER AMMONIUM DERIVATIVES
AU33735/71A AU453067B2 (en) 1970-09-21 1971-09-21 IMIDAZO [4,5-b] PYRIDINE DERIVATIVES
NL717112971A NL145553B (en) 1970-09-21 1971-09-21 PROCESS FOR PREPARING IMIDAZOLYLCARBAMIC ACID DERIVATIVES, PROCESS FOR PREPARING ANTHELMINTIC ACTIVE PREPARATIONS AND FORMED PREPARATIONS.
DE2147103A DE2147103C3 (en) 1970-09-21 1971-09-21 Imidazo square bracket to 4.5-square bracket to pyridine
ES395260A ES395260A1 (en) 1970-09-21 1971-09-21 Imidazo-4,5-b-pyridine derivatives
GB4400371A GB1318859A (en) 1970-09-21 1971-09-21 Imidazo-4,5-b-pyridine derivatives
ES403910A ES403910A1 (en) 1970-09-21 1972-06-15 Imidazo-4,5-b-pyridine derivatives
SU1936093A SU504481A3 (en) 1971-08-25 1973-07-06 Method for preparing imidazo (4,5-b) pyridine derivatives
JP4460574A JPS5117558B2 (en) 1971-08-25 1974-04-22

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7130825A FR2150236A2 (en) 1971-08-25 1971-08-25 Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use

Publications (2)

Publication Number Publication Date
FR2150236A2 true FR2150236A2 (en) 1973-04-06
FR2150236B2 FR2150236B2 (en) 1974-10-18

Family

ID=9082201

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7130825A Granted FR2150236A2 (en) 1970-09-21 1971-08-25 Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use

Country Status (5)

Country Link
JP (1) JPS5117558B2 (en)
AT (1) AT309434B (en)
CS (1) CS161784B2 (en)
FR (1) FR2150236A2 (en)
SU (1) SU504481A3 (en)

Also Published As

Publication number Publication date
AT309434B (en) 1973-07-15
JPS5117558B2 (en) 1976-06-03
JPS5029596A (en) 1975-03-25
FR2150236B2 (en) 1974-10-18
CS161784B2 (en) 1975-06-10
SU504481A3 (en) 1976-02-25

Similar Documents

Publication Publication Date Title
BR0313160A (en) Compound, pharmaceutical composition, methods for treating a condition and a susceptible neoplasm in an animal in an animal, process for preparing a compound and use of a compound.
BRPI0416605A (en) compound, process for preparing a compound, use of a compound, methods of inhibiting trk activity, treating or prophylaxis of cancer, and producing an antiproliferative effect on a warm-blooded animal and pharmaceutical composition
AU7455787A (en) Pyridine ethanolamine derivatives
DK519387D0 (en) PHARMACEUTICAL PREPARATIONS CONTAINING PROPYLENE GYCOL AND / OR POLYETHYLENE GYLOLOL AND URINENTS AS ACTIVE MAIN COMPONENTS AND USE THEREOF
SE7703975L (en) NEW POUR-ON PREPARATIONS OF ANTHELMINTIC
ES8801544A1 (en) Anthelmintic pyridinyl acylhydrazones, method of use and compositions.
FR2068413A1 (en) 1-alkyl-3-alkylamino-5-aryl-pyrazolines hypo-and hypertensives
FR2105060A1 (en) Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use
FR2150236A2 (en) Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use
ES341109A1 (en) Substituted ammonium basic addition salts of ribonucleic acid
DK230580A (en) SISOMICIN DERIVATIVES PROCEDURE FOR PREPARING THEM AND THEIR USE AS A MEDICINE
ES2070902T3 (en) ZINC AND CEFTIOFUR COMPLEXES.
NL7509922A (en) PROCEDURE FOR FEEDING CATTLE, IN PARTICULAR DURING THE REARING OF THE ANIMALS, AS WELL AS EQUIPMENT FOR PERFORMING THE PROCEDURE.
GB2008944A (en) Copper compositions for topical application in the treatment of copper deficiency in animals
ATE83379T1 (en) COCCIDIOCIDE AGENT.
Stillerman Comparison of cephaloglycin and penicillin in streptococcal pharyngitis
Ball The responses of different strains of Eimeria acervulina and Eimeria tenella to medication
FI800266A (en) 2-AMINO-8-CYCLOPROPYL-5-OXO-5,8-DIHYDRO-PYRIDO / 2,3-D / PYRIMIDINE-6-CARBONSYROR
ES442505A1 (en) Antibiotic aminoglycosides, processes of preparation and pharmaceutical compositions
GB1312129A (en) Antibiotic and process for preparing same
FR2445833A1 (en) Prepn. of water soluble salts of antibiotics - having a beta lactam ring, by treatment with sodium carbonate or bi:carbonate
ES389076A1 (en) Penicillins
Sugiura Reminiscence and experience in experimental chemotherapy of cancer
ES451449A1 (en) Penicillins
Rowlands Levamisole: anthelmintic activity in calves following dermal application